V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016495 | 270009284 | 1.74 | 57.2 | Palliative (P) | 2014-07-17 | 2014-07-18 | Rituximab | N | N | 270015466 | RITUXIMAB |
| 270016496 | 270009286 | 1.72 | 80.3 | Curative (C) | 2017-02-23 | 2017-04-28 | BEAM | 02 | N | 270015475 | BEAM |
| 270016497 | 270009287 | null | null | Curative (C) | 2017-09-15 | 2017-09-20 | Shamash LBCMVD-56 | 02 | N | 270015480 | NOT MATCHED |
| 270016498 | 270009288 | 1.84 | null | null | 2014-10-21 | 2015-02-14 | HD EuroNet-PHL-C1 Relapsed ABVD | null | null | 270015482 | NOT MATCHED |
| 270016499 | 270014342 | 1.72 | 111 | Palliative (P) | 2016-04-27 | 2016-05-06 | Capecitabine (21 day) + Irinotecan | 02 | N | 270015483 | CAPECITABINE + IRINOTECAN |
| 270016501 | 270009296 | null | null | Curative (C) | 2017-08-13 | 2017-08-13 | CHOP R - 21 days | null | null | 270015489 | CHOP R |
| 270016502 | 270009299 | null | 67.85 | null | 2016-04-02 | 2016-04-02 | Fluorouracil + Folinic Acid Weekly | null | null | 270015490 | FLUOROURACIL |
| 270016503 | 270009299 | 1.68 | 78 | Curative (C) | 2015-08-08 | 2015-09-07 | DHAP | 02 | null | 270015490 | DHAP |
| 270016504 | 270009299 | 1.74 | 94 | Not known (9) | 2014-03-01 | 2014-03-03 | Fluorouracil + Folinic Acid Weekly | N | N | 270015490 | FLUOROURACIL |
| 270016505 | 270009301 | 1.58 | 159.5 | Palliative (P) | 2018-08-01 | 2018-08-04 | Trifluridine + Tipiracil | N | N | 270015497 | TRIFLURIDINE + TIPIRACIL |
| 270016506 | 270009302 | 1.67 | 64 | Adjuvant (A) | 2013-07-26 | 2013-08-22 | CETUXIMAB + RT | null | N | 270015500 | CETUXIMAB + RT |
| 270016507 | 270009303 | 1.6 | 63 | Curative (C) | 2016-06-26 | 2016-07-29 | Capecitabine 35days + RT | N | N | 270015501 | CAPECITABINE + RT |
| 270016508 | 270009305 | 1.63 | null | Disease modification (D) | 2014-04-12 | 2014-12-22 | Shamash LBCMVD-56 | 2 | N | 270015507 | NOT MATCHED |
| 270016509 | 270009306 | null | 66 | Palliative (P) | 2015-11-23 | 2015-12-14 | CISPLATIN + FLUOROURACIL | N | N | 270015509 | CISPLATIN + FLUOROURACIL |
| 270016510 | 270009307 | 1.73 | 90 | Curative (C) | 2017-08-13 | 2017-10-14 | CHLVPP | N | N | 270015510 | CHLVPP |
| 270016511 | 270009308 | 1.72 | 60 | Curative (C) | 2017-05-23 | 2017-06-06 | DHAP | N | N | 270015514 | DHAP |
| 270016512 | 270009310 | 1.76 | 63 | Curative (C) | 2013-10-14 | 2013-10-21 | CHLORAMBUCIL + Procarbazine + VINBLASTINE | 02 | N | 270015516 | NOT MATCHED |
| 270016513 | 270009312 | 1.77 | 79.1 | Curative (C) | 2015-06-25 | 2015-07-08 | DHAP | N | N | 270015522 | DHAP |
| 270016514 | 270009314 | 1.85 | 102 | Curative (C) | 2018-04-26 | 2018-05-04 | CHOP R - 21 days | N | N | 270015525 | CHOP R |
| 270016515 | 270009316 | 1.63 | 80 | Adjuvant (A) | 2014-01-13 | 2014-01-13 | DHAP | 02 | N | 270015527 | DHAP |
| 270016516 | 270016887 | 1.76 | 95.2 | null | 2016-02-02 | 2016-02-09 | CHLVPP | N | N | 270015528 | CHLVPP |
| 270016517 | 270009319 | 0.91 | null | Palliative (P) | 2014-01-16 | 2014-03-12 | Capecitabine (21 day) + Irinotecan | N | N | 270015528 | CAPECITABINE + IRINOTECAN |
| 270016518 | 270009321 | 1.81 | 59.2 | Curative (C) | 2014-07-10 | 2015-04-04 | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + TRIPTORELIN + VINBLASTINE | 2 | N | 270015534 | NOT MATCHED |
| 270016519 | 270009325 | 1.62 | 47.5 | Palliative (P) | 2014-08-04 | 2014-08-18 | Trifluridine + Tipiracil | N | N | 270015536 | TRIFLURIDINE + TIPIRACIL |
| 270016520 | 270009325 | null | 72.8 | Palliative (P) | null | 2014-04-23 | CHLVPP | N | null | 270015536 | CHLVPP |
| 270016521 | 270009327 | 1.6 | 87 | Curative (C) | 2015-12-21 | 2015-12-25 | DHAP | N | N | 270015543 | DHAP |
| 270016522 | 270009329 | 1.74 | 72 | Adjuvant (A) | 2014-01-28 | 2014-02-03 | DHAP | N | N | 270015545 | DHAP |
| 270016523 | 270009331 | 1.65 | 77.8 | Adjuvant (A) | null | 2015-09-23 | Fluorouracil + Folinic Acid Weekly | N | N | 270015547 | FLUOROURACIL |
| 270016524 | 270014359 | 1.66 | null | Curative (C) | 2017-07-17 | 2017-07-22 | DHAP | N | N | 270015556 | DHAP |
| 270016525 | 270009334 | 0 | 44 | Curative (C) | 2014-10-22 | 2014-11-06 | Capecitabine 35days + RT | N | N | 270015557 | CAPECITABINE + RT |
| 270016526 | 270009336 | 1.79 | 84 | Palliative (P) | 2017-01-28 | 2017-02-03 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 270015560 | FLUOROURACIL |
| 270016527 | 270009337 | 1.86 | 88.9 | Palliative (P) | 2018-03-02 | 2018-03-10 | Capecitabine (14 day) + Irinotecan | N | N | 270015562 | CAPECITABINE + IRINOTECAN |
| 270016528 | 270016894 | 1.47 | 71 | Adjuvant (A) | 2017-10-05 | 2017-10-05 | CHOP R - 21 days | N | N | 270015564 | CHOP R |
| 270016529 | 270019930 | 1.7 | 89.4 | Disease modification (D) | 2016-09-13 | 2017-10-03 | null | 2 | N | 270015572 | NOT MATCHED |
| 270016530 | 270016895 | 1.59 | 68.9 | Palliative (P) | 2014-11-02 | 2014-11-02 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 270015574 | FLUOROURACIL |
| 270016531 | 270009342 | null | 70.75 | Neo-adjuvant (N) | 2014-05-20 | 2014-05-29 | Cisplatin +Fluorouracil (2 wk) | N | N | 270015578 | CISPLATIN + FLUOROURACIL |
| 270016532 | 270019668 | null | null | Neo-adjuvant (N) | null | 2014-07-23 | Bevacizumab + Oxaliplatin +MdG | N | N | 270015585 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016533 | 270019198 | 1.52 | 77 | Disease modification (D) | 2016-05-15 | 2016-05-23 | CHOP R - 21 days | 1 | Y | 270015588 | CHOP R |
| 270016534 | 270009347 | 1.61 | 98 | Curative (C) | 2016-09-14 | 2016-10-08 | CHOP R - 21 days | N | N | 270015591 | CHOP R |
| 270016535 | 270009348 | 1.74 | 67.6 | Adjuvant (A) | 2015-08-04 | 2015-08-04 | DHAP | null | null | 270015596 | DHAP |
| 270016536 | 270009350 | 1.8 | 80.4 | Palliative (P) | 2015-07-07 | 2015-12-08 | CISPLATIN + FLUOROURACIL | N | N | 270015597 | CISPLATIN + FLUOROURACIL |
| 270016537 | 270009353 | 1.77 | 61.7 | Curative (C) | 2014-06-26 | 2015-02-19 | DHAP | N | N | 270015610 | DHAP |
| 270016538 | 270009355 | null | 106 | Disease modification (D) | null | 2013-08-04 | CHLVPP | N | N | 270015616 | CHLVPP |
| 270016539 | 270009356 | 1.9 | 79 | Neo-adjuvant (N) | 2018-11-17 | 2018-11-25 | Bevacizumab + Oxaliplatin +MdG | 02 | Y | 270015617 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016540 | 270009359 | 1.46 | 76.1 | Palliative (P) | 2016-10-17 | 2017-02-19 | Bevacizumab + Oxaliplatin +MdG | N | N | 270015624 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016541 | 270009361 | 1.93 | 116.1 | Adjuvant (A) | 2017-06-12 | 2017-06-15 | Cetuximab + Radiotherapy Maint | 2 | N | 270015630 | CETUXIMAB + RT |
| 270016542 | 270018367 | null | 81.7 | Adjuvant (A) | 2015-07-01 | 2015-07-02 | Fluorouracil + Folinic Acid Weekly | N | N | 270015635 | FLUOROURACIL |
| 270016544 | 270014376 | null | 60.8 | Adjuvant (A) | 2017-04-09 | 2017-04-15 | CHLVPP | 02 | N | 270015646 | CHLVPP |
| 270016545 | 270009365 | 1.58 | 90.2 | Palliative (P) | 2014-12-25 | 2015-01-09 | Trifluridine + Tipiracil | N | N | 270015651 | TRIFLURIDINE + TIPIRACIL |
| 270016546 | 270014378 | null | null | Adjuvant (A) | 2015-03-14 | 2015-04-05 | CAPECITABINE + RT | N | N | 270015653 | CAPECITABINE + RT |